dr. galsky on targeted therapies in bladder cancer
Published 10 years ago • 92 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:20
dr. galsky on the role of ipilimumab for the treatment of bladder cancer
-
0:59
dr. galsky on progression on immunotherapy in bladder cancer
-
2:25
dr. galsky discusses progression in patients with metastatic bladder cancer
-
1:58
dr. galsky discusses combination immunotherapy in bladder cancer
-
0:59
dr. galsky on resistance to checkpoint blockade in metastatic bladder cancer
-
1:07
dr. galsky on ipilimumab in bladder cancer
-
1:54
targeted therapy effective for patients with advanced bladder cancer and specific gene mutations
-
2:14
how does targeted therapy treat bladder cancer?
-
1:09
dr. galsky on the role of ipilimumab in bladder cancer
-
1:35
dr. galsky on neoadjuvant immune checkpoint blockade in bladder cancer
-
1:36
dr. galsky discusses neoadjuvant immunotherapy in bladder cancer
-
44:28
breakthroughs in bladder cancer immunotherapy, with matthew galsky
-
1:03
dr. inman discusses the biology of bladder cancer
-
14:16
new emerging treatment options and targeted therapies for bladder cancer
-
1:35
matthew galsky gives an overview of bladder cancer
-
7:18
case 3: experience with fgfr-targeted therapies in bladder cancer
-
1:53
discussing recent advances and clinical trials in bladder cancer
-
2:00
dr. matthew galsky on fatal adverse events associated with mtor inhibitors
-
2:21
dr. galsky on maintenance pembrolizumab in urothelial cancer